Iota Communications (IOTC) 10-Q 14 Jan 15 2015 Q2 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Nov. 30, 2014	Jan. 12, 2015
Document Information [Line Items]
Entity Registrant Name	ARKADOS GROUP, INC.
Entity Central Index Key	1095130
Current Fiscal Year End Date	-26
Entity Filer Category	Smaller Reporting Company
Trading Symbol	AKDS
Entity Common Stock, Shares Outstanding		153,171,281
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	30-Nov-14
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2015

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Nov. 30, 2014	31-May-14
Current assets:
Cash	$271	$118,505
Accounts receivable	20,000	0
Prepaid expenses	608	11,224
Total current assets	20,879	129,729
Total assets	20,879	129,729
Current liabilities:
Accounts payable and accrued expenses	693,255	661,868
Accrued income tax	63,082	98,922
Due to related party	0	130,000
Debt subject to equity being issued	1,224,591	2,420,374
Notes payable, net of discount of $188,600 and $231,818, respectively	1,357,233	617,339
Total current liabilities	3,338,161	3,928,503
Long term liabilities:
Notes payable, net of discount of $0 and $77,445, respectively	0	322,555
Total liabilities	3,338,161	4,251,058
Commitments
Stockholders' deficiency:
Convertible preferred stock, $.0001 par value; 5,000,000 shares authorized, zero shares outstanding	0	0
Common stock, $.0001 par value; 600,000,000 shares authorized; 153,171,281 and 75,863,928 issued and outstanding	15,317	7,585
Common stock to be issued; 0 and 37,850,479 shares	0	1,835,486
Additional paid-in capital	33,869,330	29,720,041
Accumulated deficit	-37,201,929	-35,684,441
Total stockholders' deficiency	-3,317,282	-4,121,329
Total liabilities and stockholders' deficiency	$20,879	$129,729

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Nov. 30, 2014	31-May-14
Notes Payable Unamortized Discount Current (in dollars)	$188,600	$231,818
Notes Payable Unamortized Discount Noncurrent (in dollars)	$0	$77,445
Convertible preferred stock, par value (in dollars per share)	$0.00	$0.00
Convertible preferred stock, shares authorized	5,000,000	5,000,000
Convertible preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	600,000,000	600,000,000
Common stock, shares issued	153,171,281	75,863,928
Common stock, shares outstanding	153,171,281	75,863,928
Common stock to be issued shares	0	37,850,479

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014	Nov. 30, 2013
Net sales	$78,996	$0	$118,996	$0
Operating expenses:
Selling and general and administrative	254,194	436,660	1,441,368	658,815
Research and development	88,245	16,188	140,437	19,969
Total operating expenses	342,439	452,848	1,581,805	678,784
Loss from operations	-263,443	-452,848	-1,462,809	-678,784
Other income (expenses):
Interest expense	-143,719	-95,819	-259,383	-195,273
Other income	124,793	0	124,793	0
Gain on settlement of debt	44,071	0	44,071	0
Total other income (expenses)	25,145	-95,819	-90,519	-195,273
Loss before provision for income taxes	-238,298	-548,667	-1,553,328	-874,057
Provision for income tax benefits	35,840	0	35,840	0
Net loss	($202,458)	($548,667)	($1,517,488)	($874,057)
Loss per common share - basic and diluted (in dollars per share)	$0	($0.01)	($0.01)	($0.02)
Weighted average of common shares outstanding - basic and diluted (in shares)	153,171,281	57,145,153	138,681,326	52,999,282

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
Cash flows from operating activities:
Net loss	($1,517,488)	($874,057)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount	191,663	156,016
Issuance of common stock for services	1,000,000	217,000
Issuance of warrants for services	37,000	2,834
Reversal of accounts payable	-124,793	0
Gain on settlement of debt	-44,071	0
Interest accrued on debt subject to equity being issued	17,753	0
Changes in operating assets and liabilities:
Accounts receivable	-20,000	0
Prepaid expenses	10,616	-12,333
Accounts payable and accrued expenses	166,926	76,175
Accrued income tax	-35,840
Net cash used in operating activities	-318,234	-434,365
Cash flows from financing activities:
Proceeds from convertible debt	200,000	400,000
Net cash provided by financing activities	200,000	400,000
Net decrease in cash	-118,234	-34,365
Cash at beginning of period	118,505	345,126
Cash at end of period	271	310,761
Schedule of non-cash transactions:
Warrants issued to former employees to settle debt subject to equity being issued	747,536	0
Common stock issued or to be issued for debt subject to equity being issued	466,000	125,000
Common stock issued for transactions previously classified as common stock to be issued	1,835,486	0
Valuation of beneficial conversion feature of debt raise	71,000	107,500
Refinance of due to related party	130,000	0
Common stock to be issued for bridge notes and accrued interest	0	73,428
Warrants to be issued for bridge notes and accrued interest	0	19,047
Common stock to be issued for promissory note and accrued interest	0	121,736
Common stock to be issued for accounts payable	0	338,806
Supplemental disclosure of cash flow information:
Interest paid	0	0
Income taxes paid	$0	$0

DESCRIPTION_OF_BUSINESS

DESCRIPTION OF BUSINESS	6 Months Ended
	Nov. 30, 2014
Accounting Policies [Abstract]
Business Description and Basis of Presentation [Text Block]	1	DESCRIPTION OF BUSINESS
	Arkados Group, Inc. (the “Company”) conducts business activities principally through Arkados, Inc., which is a wholly owned subsidiary.
	The Company underwent a significant restructuring following December 23, 2010, during which substantially all of its assets were acquired by STMicroelectronics (sometimes referred to hereinafter as the “Asset Sale”), as disclosed in the 8-K filed December 29, 2010 and further described (as to the closing) in the 8-K filed July 12, 2011. Settlements reached in connection with the Asset Sale and the fulfillment of obligations in connection therewith, have just recently been (post the period covered by this report) substantially completed.
	Following the sale of its assets associated with the manufacture of microchips, the Company shifted its focus towards software and hardware design and developing solutions that enable machine to machine communications for the Internet of Things (IoT). The Company’s solutions support smart grid and smart home applications primarily in the areas of home and building automation and energy management and are uniquely designed to drive a wide variety of wireless and powerline communication (PLC)-based products, such as sensors, gateways, video cameras, appliances and other devices.
	The accompanying condensed consolidated financial statements as of November 30, 2014 (unaudited) and May 31, 2014 and for the three and six month periods ended November 30, 2014 and 2013 (unaudited) have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q and Regulation S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. These financial statements and the information included under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" should be read in conjunction with the audited financial statements and explanatory notes for the year ended May 31, 2014 as disclosed in our annual report on Form 10-K for that year. The results of the three and six months ended November 30, 2014 (unaudited) are not necessarily indicative of the results to be expected for the pending full year ending May 31, 2015.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Nov. 30, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
		a.	Basis of Presentation - The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred net losses of approximately $37.2 million since inception, including a net loss of approximately $1.5 million for the six months ended November 30, 2014. Additionally, the Company still had both working capital and stockholders’ deficiencies at November 30, 2014 and May 31, 2014 and negative cash flow from operations since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management expects to incur additional losses in the foreseeable future and recognizes the need to raise capital to remain viable. The accompanying consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.
		b.	Principles of consolidation - The consolidated financial statements include the accounts of Arkados Group, Inc. (the “Parent”), and its wholly-owned subsidiaries, which include: Arkados Energy Solutions, LLC, Arkados, Inc., CDKnet, LLC and Creative Technology, LLC. Currently, Arkados, Inc. is the only active entity with operations. Intercompany accounts and transactions have been eliminated in consolidation.
		c.	Revenue Recognition - Revenues from software licensing are recognized in accordance with ASC 985-605, "Software Revenue Recognition." Accordingly, revenue from software licensing is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collectability is probable.
	The Company intends to enter into arrangements with end users for items which may include software license fees, and services or various combinations thereof. For each arrangement, revenues will be recognized when evidence of an agreement has been documented, the fees are fixed or determinable, collection of fees is probable, delivery of the product has occurred and no other significant obligations remain.
	License revenues are recognized at the time of delivery of the software and all other revenue recognition criteria discussed above have been met.
		d.	Cash and cash equivalents - The Company considers investments in highly liquid instruments with a maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents at both November 30, 2014 and May 31, 2014.
		e.	Fair Value of Financial Instruments - The carrying value of cash, accounts receivable, other receivables, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. As defined in Accounting Standards Codification (“ASC”) Topic No. 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.
	The three levels of the fair value hierarchy defined by ASC Topic No. 820 are as follows:
	Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
	Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
		f.	Earnings (Loss) Per Share (“EPS”) - Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes.
	The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares.
			Three and Six Months ended
			November 30,
			2014		2013
	Convertible notes			63,475,550		50,000,000
	Stock options			35,437,500		2,960,000
	Warrants			92,479,696		5,095,000
	Potentially dilutive securities			191,392,746		58,055,000
		g.	Stock Based Compensation - In computing the impact, the fair value of each option and/or warrant is estimated on the date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility; and expected remaining lives of the awards. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and the Company uses different assumptions, the Company’s stock-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the amount of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what we have recorded in the current period.
	Stock based compensation expense was $37,000 and $219,834 for the three months ended November 30, 2014 and 2013, respectively, and $1,037,000 and $219,834 for the six months ended November 30, 2014 and 2013, respectively. The expense was included in selling and general and administrative expenses. See Note 6h.
		h.	Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.
		i.	Research and Development –All research and development costs are expensed as incurred.
		j.	New Accounting Pronouncements –
	In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” The amendments in ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in ASC 605, “Revenue Recognition,” and most industry-specific guidance, and creates an ASC 606, “Revenue from Contracts with Customers.”
	The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps
	Step 1: Identify the contract(s) with a customer.
	Step 2: Identify the performance obligations in the contract.
	Step 3: Determine the transaction price.
	Step 4: Allocate the transaction price to the performance obligations in the contract.
	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
	ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted. The Company’s has not yet determined the effect to the current consolidated financial statements by the adoption of ASU 2014-09.
	In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Subtopic 205-40) – Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this Update provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this Update are effective for public and nonpublic entities for annual periods ending after December 15, 2016 and early adoption is permitted.
	All newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.
		k.	Reclassification –
	Certain amounts in the consolidated statement of cash flow for the six months ended November 30, 2013 were reclassified to conform to the current period presentation. For the six months ended November 30, 2013, the Company did not originally segregate issuances of common stock and warrants for services.

SALE_OF_LICENSE_AND_IP_AGREEME

SALE OF LICENSE AND IP AGREEMENTS	6 Months Ended
	Nov. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	3. SALE OF LICENSE AND IP AGREEMENTS
	In December 2010, the Company entered into an agreement to sell substantially all of the assets used in the Company’s business of designing, developing and selling semiconductor products that incorporate power line communications and networking services and offering services related thereto (the “Asset Sale”) to STMicroelectronics, Inc. (“ST US”), a subsidiary of STMicroelectronics N.V. (“ST”), pursuant to an Asset Purchase Agreement, by and among the Company, the Companies Arkados, Inc., and Arkados Wireless Technologies, Inc. subsidiaries (collectively, “Arkados”) and ST US, dated as of December 23, 2010 (the “Purchase Agreement”).  At the same time, the Company granted a license (the “License”) to ST US to use the Company’s intellectual property assets included in the Asset Sale pending the closing of such sale. In exchange for granting the License, the Company received gross proceeds of $7 million. The Asset Sale was predicated on the Company settling its secured debt and a significant part of its unsecured debt and closed in June, 2011, whereupon the Company received $4 million.  At the time the Asset Sale was completed, ST US agreed to license back certain intellectual property on a non-exclusive basis to Arkados to facilitate the continuation and expansion of the Company’s home automation business, support the Company’s customers and, with adequate financing (of which there is no assurance), permit the Company to continue the development and marketing of smart grid products.   ST US hired substantially all of the Company’s engineering and semiconductor employees (including Oleg Logvinov, the Company’s former CEO and director, who was engaged in and directed the semiconductor business).
	Substantially all of the proceeds received pursuant to the License and the Asset Sale, after payment of expenses related to the transactions, were used to settle approximately $20 million of the Company’s outstanding secured debt issued during the period from December 2004 to August 31, 2008 (which was in default) and pay employees $1.4 million of $5.2 million due them.  The remainder of the proceeds received by the Company was used to pay other creditors and expenses incurred in connection with the Asset Sale to the extent funds were available to do so.
	As a condition to entering into the Purchase Agreement and the License, ST US required that the Company have written settlement agreements and releases with all of our secured creditors as well as all of our employees.  Under the settlement agreements with creditors, the creditors agreed to settle the amounts owed  (approximately $30,000,000), for an aggregate amount of $10,862,241 in cash, notes payable of $818,768 and another $5,259,926 in common stock of the Company which has yet to be issued. Of the cash settlements, $7,000,000 was paid in December 2010 out of proceeds from the $7,000,000 license fee received pursuant to the License (received in December, 2010), and $3,862,241 was paid at the closing out of proceeds from the Asset Sale (received in June, 2011).  In exchange for the settlement amount, the secured creditors agreed to release their security interest in Arkados’ assets and most secured creditors released Arkados from any and all additional claims, if any, that the secured creditors may have had against Arkados.  The secured creditors also agreed that ST and its affiliates were third party beneficiaries to the settlement agreements. Under the settlement agreements with the Company’s employees, the employees agreed to accept an aggregate of $1,429,949 and an amount of the Company’s equity rights to be negotiated after the closing as payment for back wages and unreimbursed expenses.  The cash payment was paid to employees in December 2010 out of the license fee paid to the Company by ST US. Also, as a condition to entering into the Purchase Agreement and the License, the Company entered into standstill agreements with holders of approximately $2,100,000 of unsecured debt pursuant to which those unsecured creditors agreed, among other things, not to exercise remedies that they may have as creditors of Arkados, not to sell or transfer their debt, to release ST and its affiliates from any and all claims that they may have against ST, if any, and not to sue ST for any dealings that the creditors had with Arkados.
	The Company is negotiating with those few remaining outstanding unsecured debt holders from the period prior to the ST US Asset Sale for which it has not reached agreement, compromise, or convert outstanding debt into equity and thereby facilitate raising additional investor capital for the Company’s business. The amounts that the debt holders have agreed to settle through the receipt of the Company’s equity are labeled as “Debt Subject to Equity Being Issued” on the balance sheet. These settlements are binding commitments, however, the Company is awaiting required information from these debt holders in order to issue the equity and discharge such obligations.

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	6 Months Ended
	Nov. 30, 2014
Payables and Accruals [Abstract]
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]		4	ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	As of November 30, 2014 and May 31, 2014, accounts payable and accrued expenses consist of the following amounts:
			November 30, 2014		May 31, 2014
			(Unaudited)
	Accounts payable		$	375,494	$	396,324
	Accrued interest			176,956		137,736
	Accrued other			140,805		127,808
			$	693,255	$	661,868
	Accounts payable transactions included the following:
	On September 10, 2013, the Company entered into a Settlement Agreement and Release with an unsecured creditor whereby the Company was released from all existing debt, including interest, in exchange for the issuance of 23,776,513 shares of common stock within 90 days of the signing of the Agreement. The Company issued such shares under this Settlement Agreement in September 2014. As of both November 30, 2014 and May 31, 2014, there was $0 of payables due. See Note 6i.
	On September 19, 2013, the Company entered into a General Release with an unsecured creditor whereby the Company was released from all accounts payable totaling $130,863, in exchange for the issuance of common stock. The shares of common stock were issued on February 3, 2014. See Note 6e.
	On November 20, 2013, the Company entered into a Settlement Agreement and General Release with an unsecured creditor whereby the Company was released from all existing debt, including interest, totaling $207,943, in exchange for the issuance of 5,682,407 shares of common stock. The shares of common stock were issued on February 3, 2014. See Note 6e.
	In fiscal 2015, the Company determined that certain accounts payable had been settled in prior periods and should be written off. Balances totaling $124,793 were reversed and recognized as other income.

NOTES_PAYABLE_RELATED_PARTY_PA

NOTES PAYABLE, RELATED PARTY PAYABLES AND DEBT SUBJECT TO EQUITY BEING ISSUED	6 Months Ended
	Nov. 30, 2014
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]		5	NOTES PAYABLE, RELATED PARTY PAYABLES AND DEBT SUBJECT TO EQUITY BEING ISSUED
	Notes Payable
	As a result of the sale of the Company’s Asset Sale to STUS, the notes payable and convertible debentures of $17,269,689 and the related accrued interest of $3,671,137 as of May 31, 2010, have been settled in part with the December 2010 closing in the amount of $5,570,059 and the balance in June 2011 closing with cash of $3,526,523, an undetermined amount of equity yet to be issued and $688,768 of remaining notes payable as of May 31, 2012. In fiscal 2014, the Company received loans of $400,000. As of May 31, 2014, there was $939,894 of notes payable, net of debt discounts of $309,263. As of November 30, 2014, there was notes payable of $1,357,233, net of debt discounts of $188,600. All notes payable mature on or before October 31, 2015 and as such, are classified as current liabilities on the consolidated balance sheet.
	Notes payable transactions include the following:
	FY 2013 (Year Ended May 31, 2013) Transactions:
	In November 2012, the Company received a loan in the form of a Convertible Note in the principal amount of $180,000. The Convertible Note bears interest at 6% per year and was scheduled to mature on November 15, 2014. In November 2014, the maturity date was extended to January 15, 2015. At any time during the term of the Convertible Note, the holder has the right to convert any unpaid portion of the Convertible Note into shares of common stock at a conversion price of $0.01 per share. The beneficial conversion feature was fair valued at $180,000 and was amortized over the life the debt instrument.
	In December 2012, the Company received a loan in the form of a Convertible Note in the principal amount of $20,000. The Convertible Note bears interest at 6% per year and was scheduled to mature on November 15, 2014. In November 2014, the maturity date was extended to January 31, 2015. Under the terms of the Convertible Note, if the Convertible Note is not paid upon maturity, the interest rate increases to 12% per year. At any time during the term of the Convertible Note, the holder has the right to convert any unpaid portion of the Convertible Note into shares of common stock at a conversion price of $0.01 per share. The beneficial conversion feature was fair valued at $20,000 and was amortized over the life the debt instrument.
	On April 22, 2013, the Company executed two Convertible Notes for loans in principal amount of $40,000 each. Each Convertible Note bears interest at 6% per year and matures on April 30, 2015. At any time during the term of the Convertible Notes, the holders have the right to convert any unpaid portion of the Convertible Notes into shares of common stock at a conversion price of $0.02 per share for both Convertible Notes. The beneficial conversion feature was fair valued at $40,000 each and is being amortized over the life the debt instruments.
	On April 22, 2013, the Company executed a Convertible Note for a loan in the principal amount of $120,000. The Convertible Note bears interest at 6% per year and matures on April 30, 2015. At any time during the term of the Convertible Note, the holder has the right to convert any unpaid portion of the Convertible Note into shares of common stock at a conversion price of $0.02 per share. The beneficial conversion feature was fair valued at $120,000 and is being amortized over the life the debt instrument.
	On May 2, 2013, the Company executed a Convertible Note for a loan in the principal amount of $200,000. The Convertible Note bears interest at 6% per year and matures on April 30, 2015. At any time during the term of the Convertible Note, the holder has the right to convert any unpaid portion of the Convertible Note into shares of common stock at a conversion price of $0.02 per share. The beneficial conversion feature was fair valued at $200,000 and is being amortized over the life the debt instrument.
	FY 2014 (Year Ended May 31, 2014) Transactions:
	On September 6, 2013, the Company entered into a Settlement Agreement and General Release with a prior director who was also an unsecured creditor, whereby he released all existing debt and accrued interest totaling $18,190, in exchange for the issuance of 1,204,630 shares of common stock. The shares were issued on February 3, 2014. See Note 6c.
	On September 9, 2013, the Company entered into a Settlement Agreement and General Release with an unsecured creditor whereby the Company was released from all existing debt and accrued interest totaling $74,286, in exchange for the issuance of 2,478,417 shares of common stock and the issuance of a warrant to exercise 1,435,000 shares of stock at $0.04 per share for a term of three years through September 9, 2016. The shares were issued on February 3, 2014. See Note 6c.
	On September 19, 2013, the Company entered into a General Release with an unsecured creditor whereby the Company was released from a promissory note, including interest, totaling $121,736, in exchange for the issuance of common stock. The shares of common stock were issued on February 3, 2014. See Note 6e.
	On October 28, 2013, the Company executed a Convertible Note for a loan in the principal amount of $200,000. The Convertible Note bears interest at 6% per year and matures on October 31, 2015. At any time during the term of the Convertible Note, the holder has the right to convert any unpaid portion of the Convertible Note into shares of common stock at a conversion price of $0.04 per share. The beneficial conversion feature was fair valued at $7,500 and is being amortized over the life the debt instrument.
	On November 12, 2013, the Company executed a Convertible Note for a loan in the principal amount of $200,000. The Convertible Note bears interest at 6% per year and matures on October 31, 2015. At any time during the term of the Convertible Note, the holder has the right to convert any unpaid portion of the Convertible Note into shares of common stock at a conversion price of $0.04 per share. The beneficial conversion feature was fair valued at $100,000 and is being amortized over the life the debt instrument.
	Effective June 1, 2009, the Company adopted the provisions of EITF 07-05 “Determining Whether an Instrument (or Embedded Feature) is Indexed to a Company's Own Stock,” which was codified into ASC 815, “Derivatives and Hedging” (“ASC 815”) ASC 815 applies to any freestanding financial instruments or embedded features that have characteristics of a derivative and to any freestanding financial instruments that are potentially settled in an entity’s own common stock. The Company had 11,075,004 of warrants with exercise reset provisions, with its debt issuances over the years, which are considered freestanding derivative instruments. ASC 815 requires that these warrants be recorded as liabilities as they are no longer afforded equity treatment. The assumptions were as follows: risk free rates from 1.32% to 1.39%, expected life terms ranging from 0.5 years to 2.0 years, an expected volatility range of 206% to 251% depending on the term of such equity contracts and a dividend rate of 0.0%. The fair value of the warrants issued and outstanding at May 31, 2010, attributed to this derivative liability has been determined to be immaterial due to the low stock price in comparison to the exercise price, hence there was no adjustment to make upon adoption of this accounting standard. As of May 31, 2014, all of these warrants expired
	FY 2015 (Year Ended May 31, 2015) Transactions:
	On August 11, 2014, the Company executed a Convertible Note for a loan in the principal amount of $100,000. The Convertible Note bears interest at 6% per year and matures on October 31, 2015. At any time during the term of the Convertible Note, the holder has the right to convert any unpaid portion of the Convertible Note and accrued interest into shares of common stock at a conversion price of $0.02 per share. The beneficial conversion feature was fair valued at $35,500 and is being amortized over the life the debt instrument.
	On August 12, 2014, the Company executed a Convertible Note for a loan in the principal amount of $100,000. The Convertible Note bears interest at 6% per year and matures on October 31, 2015. At any time during the term of the Convertible Note, the holder has the right to convert any unpaid portion of the Convertible Note and accrued interest into shares of common stock at a conversion price of $0.02 per share. The beneficial conversion feature was fair valued at $35,500 and is being amortized over the life the debt instrument.
	On September 10, 2014, the Company executed two Convertible Notes to refinance due to related party, a previously issued outstanding note payable and accrued interest totaling $174,071. Each of these Convertible Notes has a principal balance of $65,000, bear interest at 6% per year and mature on October 31, 2015. At any time during the term of the Convertible Notes, the holders have the right to convert any unpaid portion of the Convertible Notes and accrued interest into shares of common stock at a conversion price of $0.04 per share. There was no beneficial conversion feature. The Company recognized a gain on the settlement of debt of $44,071 for each of the three and six months ended November 30, 2014.
	Related Party Payables
	The Company received an aggregate of $130,000 from two of its then directors during the first quarter of 2012. As discussed above, these payables were refinanced.
	Debt Subject To Equity Being Issued
	As a direct result of the Sale of the License and IP Agreements to STUS and the mandate to obtain debt releases, the Company has been able to reach settlements with its secured creditors and employees, with cash payments to the secured creditors made as of the December 2010 and June 2011 closings. Nothing further is owed the Company’s secured creditors. There remains, however, approximately $179,000 and $927,000 of payments due the former employees as of November 30, 2014 and May 31, 2014, respectively.
	The continuing settlements with unsecured and related parties resulted in gains being recorded in the amount of $482,784 in fiscal 2012. As of November 30, 2014 and May 31, 2014, there remained $1,224,591 and $2,420,374 of debts to be settled via cash payments and/or the issuance of equity on as yet to be determined or negotiated terms. The majority of debt holders who have settled have agreed to accept equity for their remaining debt.
	On January 6, 2013, the Company and Andreas Typaldos (“Typaldos”), former officer and director, entered into a Separation and Release Agreement (Separation Agreement”). Under the Separation Agreement, all prior agreements with Typaldos will be terminated and certain debts and obligations to Typaldos will be released in exchange for (1) $15,920 and (2) 14,073,966 shares of common stock. In addition, $19,000 will be paid to Typaldos’ son for an existing loan with the Company. The Company issued such shares under this Separation Agreement in September 2014. As of both November 30, 2014 and May 31, 2014, there was $0 of payables due to Typaldos. See Note 6j.
	FY 2014 (Year Ended May 31, 2014):
	On September 11, 2013, the Company entered into a Settlement Agreement and General Release with a vendor in respect of all past due amounts prior to November 1, 2012 in exchange for a payment by the Company of $15,000 in cash and the issuance of 3,500,000 shares of the Company’s stock valued at $125,000. The Company paid $7,500 in December 2013 and $7,500 in March 2014. The Company issued the shares of common stock on February 3, 2014. See Note 6d.
	In April 2014, the Company entered into final supplemental agreements with various former employees to settle all outstanding claims. The Company issued warrants to purchase 67,376,284 shares of common stock at $0.04 per share for a five-year period to settle claims totaling $2,695,052.
	FY 2015 (Year Ended May 31, 2015):
	In fiscal 2015, the Company entered into final supplemental agreements with former employees to settle all outstanding claims. The Company issued warrants to purchase 18,688,412 shares of common stock at $0.04 per share for a five-year period to settle claims totaling $747,537.
	During the period from June 1, 2014 to November 30, 2014, the Company entered into final supplemental agreements with bridge note holders to settle all outstanding claims. The Company agreed to issue 19,456,874 shares of common stock to settle claims totaling $466,000. The shares were issued in September 2014. See Note 6k.
	As of November 30, 2014, debt subject to equity being issued totaled $1,224,591.

STOCKHOLDERS_DEFICIENCY

STOCKHOLDERS' DEFICIENCY	6 Months Ended
	Nov. 30, 2014
Equity [Abstract]
Stockholders Equity Note Disclosure [Text Block]	6	STOCKHOLDERS’ DEFICIENCY
	Increase in authorized shares
	A majority of the Company’s stockholders authorized, at the recommendation of the Company’s Board of Directors, an increase the number of shares of common stock from 100,000,000 to 600,000,000. The increase became effective on March 17, 2014
	FY 2013 (Year Ended May 31, 2013)
		a.	The Company raised $600,000 of debt with conversion features, converting such debt into equity at the option of the holders at exercise prices ranging from $0.01 to $0.02 a share. The beneficial conversion rights have been valued at $600,000 and are being amortized over the life of the related debt.
	FY 2014 (Year Ended May 31, 2014)
		b.	The Company raised $400,000 of debt with conversion features, converting such debt into equity at the option of the holders at an exercise price of $0.04 a share. The beneficial conversion rights have been valued at $ 107,500 and are being amortized over the life of the related debt.
		c.	As described above, the Company signed settlement agreements with two bridge note holders and agreed to issue 3,683,047 shares of its common stock for $73,428 of bridge notes and accrued interest. Such shares would be exempt from registration.   In addition, the Company agreed to issue a warrant to purchase 1,435,000 shares of common stock at a price of $0.04 per share to one note holder for $19,047 of bridge notes and accrued interest.   The Company issued the shares on February 3, 2014. Prior to the issuance date, such shares were classified as common stock to be issued.
		d.	As described above, the Company agreed to issue 3,500,000 shares of its common stock for $125,000 of debt subject to equity being issued.   Such shares are exempt from registration.   The Company issued the shares on February 3, 2014. Prior to the issuance date, such shares were classified as common stock to be issued.
		e.	As described above, the Company signed settlement agreements with two vendors and agreed to issue 6,682,407 shares of its common stock for $338,806 of accounts payable and $121,736 of a promissory note and accrued interest.   Such shares are exempt from registration. The Company issued the shares on February 3, 2014. Prior to the issuance date, such shares were classified as common stock to be issued.
		f.	The Company agreed to issue 3,100,000 shares of its common stock for $217,000 to two consultants and warrants to purchase 3,000,000 shares of Company common stock to one of the consultants valued at $2,834.   The values of the issuances were expensed as there were no material disincentive terms in these agreements with the two consultants. Such shares are exempt from registration. The Company issued the shares on February 3, 2014. Prior to the issuance date, such shares were classified as common stock to be issued.
		g.	In March 2014, the Company raised $400,000 through the sale of 10,000,000 shares to accredited investors.
	FY 2015 (Year Ended May 31, 2015)
		h.	On July 16, 2014, the Company issued 20,000,000 shares of common stock to a consultant under the terms of a consulting agreement.  The shares were valued at $0.05 per share which was the price of the common stock on the date of the consummation of an agreement with a customer.  See Note 10.
		i.	As described above, the Company signed a Settlement Agreement and Release with an unsecured creditor and agreed to issue 23,776,513 shares of common stock for $550,000 of accounts payable and $310,977 of a promissory note and accrued interest. The Company issued such shares under this Settlement Agreement in September 2014. Prior to the issuance date, such shares were classified as common stock to be issued.
		j.	As described above, the Company entered into a Separation Agreement with Typaldos and agreed to issue 14,073,966 shares of common stock as part of the Agreement. The Company issued such shares under this Separation Agreement in September 2014. Prior to the issuance date, such shares were classified as common stock to be issued.
		k.	As described above, the Company entered into final supplemental agreements with bridge note holder to settle all outstanding claims. The Company agreed to issue 19,456,874 shares of common stock to settle claims totaling $466,000. The shares were issued in September 2014. Prior to the issuance date, such shares were classified as common stock to be issued.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	6 Months Ended
	Nov. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]		7	STOCK-BASED COMPENSATION
	The Company accounted for its stock based compensation in accordance with the fair value recognition provisions of FASB ASC Topic 718, Compensation – Stock Compensation (“ASC 718”).
	A. Options
	Compensation based stock option activity for qualified and unqualified stock options are summarized as follows:
					Weighted
					Average
			Shares		Exercise Price
	Outstanding at May 31, 2013			2,960,000	$	0.29
	Granted			35,437,500		0.04
	Exercised			—		—
	Expired or cancelled			-960,000		0.36
	Outstanding at May 31, 2014			37,437,500		0.05
	Granted			—		—
	Exercised			—		—
	Expired or cancelled			-2,000,000		0.25
	Outstanding at November 30, 2014			35,437,500	$	0.04
	The following table summarizes information about options outstanding and exercisable at November 30, 2014:
			Options Outstanding and exercisable
			Number		Weighted-		Weighted-		Number
			Outstanding		Average		Average		Exercisable
					Remaining Life		Exercise
					In Years		Price
	Range of exercise prices:
	$0.04			35,437,500		9.39	$	0.04		35,437,500
	The compensation expense attributed to the issuance of the options and warrants will be recognized as they vest/earned. These stock options and warrants are exercisable for three to ten years from the grant date.
	The employee stock option plan stock options are exercisable for ten years from the grant date and vest over various terms from the grant date to three years.
	B. Warrants
	The issuance of warrants attributed to debt issuances are summarized as follows:
					Weighted
					Average
			Shares		Exercise Price
	Outstanding at May 31, 2013			2,350,080	$	0.19
	Granted			72,031,284		0.04
	Exercised			—		—
	Expired or cancelled			-2,350,080		0.7
	Outstanding at May 31, 2014			72,031,284		0.04
	Granted			20,448,412		0.04
	Exercised			—		—
	Expired or cancelled			—		—
	Outstanding at November 30, 2014			92,479,696	$	0.04
	The following table summarizes information about warrants outstanding and exercisable at November 30, 2014:
			Outstanding and exercisable
			Number		Weighted-		Weighted-		Number
			Outstanding		average		Average		Exercisable
					remaining life		Exercise
					in years		Price
	Range of exercise prices:
	$0.00 to $0.04			89,479,696		4.65	$	0.04		89,479,696
	$0.05 to $0.20			3,000,000		1.98		0.15		3,000,000
				92,479,696		4.56	$	0.04		92,479,696
	Warrants issuances were as follows:
	1.    18,688,412 warrants were issued in exchange for certain past due indebtedness outstanding. Such warrants were determined to have been issued at fair value since such settlements were negotiated by the Company with each debt holder.
	2.    1,760,000 warrants were issued to a consultant for services rendered under a consulting contract. The warrants issued were valued using the Black-Scholes option pricing model under the following assumptions: stock price - $0.02 - $0.06; strike price - $0.04; expected volatility - 100.00%; risk-free interest rate - 1.5%; dividend rate - 0%; and expected term - 3 years. See Note 10.

LICENSE_AGREEMENTS

LICENSE AGREEMENTS	6 Months Ended
	Nov. 30, 2014
License Agreements [Abstract]
License Agreements [Text Block]	8	LICENSE AGREEMENTS
	The Company earned all of its revenue from one customer under the following agreements.
	Master Agreement – License of (“PEMS-SF”™)
	On July 10, 2014, the Company entered into a Master Agreement to license our Process and Event Management System (“PEMS-SF”™) with Tatung Corporation (“Tatung”).
	The basic fee generation structure of the Agreement allows for (1) a one-time licensing fee for each PEMS-SF-enabled stations or subsystems installed, (2) separate fees of up to 10% of the software fees for software updates, maintenance and technical support, (3) on-going service fees based on units of products manufactured utilizing PEMS-SF; and (4) an annual service fee for cloud-based services and data storge.
	The Master Agreement has a year-to-year term but can be terminated by either party upon sixty (60) days’ advance written notice. Upon termination or expiration of this agreement, we are not required to provide any continuing or ongoing processing of data or other services that, pursuant to a sub-agreement, are discontinued upon termination, however, the customer shall retain any perpetual rights granted in a sub-agreement or schedule. The term of any sub-agreements is concomitant and co-terminus with the Master Agreement term.
	Revenue recognized under the Master Agreement amounted to $58,996 and $98,996 for the three and six months ended November 30, 2014.
	Agreement – License of Meter Collar and Bridge Programmable Logic Controllers
	In October 2014, the Company entered into a year-to-year term agreement with Tatung to license its meter collar and bridge programmable logic controllers. The license is paid on a per copy (ordered) fee, and is on a perpetual, worldwide, non-exclusive, transferable basis.
	Revenue recognized under the agreement amounted to $20,000 for both the three and six months ended November 30, 2014.

PROVISION_FOR_INCOME_TAX_BENEF

PROVISION FOR INCOME TAX BENEFITS	6 Months Ended
	Nov. 30, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	9	PROVISION FOR INCOME TAX BENEFITS
	The provision for income tax benefits of $35,840 for both the three and six months ended November 30, 2014 represents the reversal of over accruals from prior periods.

COMMITMENTS

COMMITMENTS	6 Months Ended
	Nov. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	10	COMMITMENTS
	The Company sublets office space on a month-to-month basis from a company affiliated with its chief executive officer at the rate of $1,668 per month. Rent expense for both the three months ended November 30, 2014 and 2013 was $5,004. Rent expense for both the six months ended November 30, 2014 and 2013 was $10,008.
	On July 1, 2013, the Company entered into a consulting agreement whereby the consultant would be paid in shares of the Company’s common stock in lieu of cash after achieving certain milestones. 20 million shares were issued on July 16, 2014 upon the consummation of an agreement with a customer, another 30 million shares each will be issued upon gross revenue receipts of $500,000, $2,000,000 and $4,000,000, respectively.
	On November 20, 2013, the Company entered into a one-year consulting agreement whereby the consultant received 3,000,000 shares of common stock and warrants to purchase 3,000,000 shares of common stock exercisable at prices ranging from $0.10 to $0.20 per share. In addition, the consultant is entitled to a 7% finder’s fee on the gross consideration paid for an acquisition identified by the consultant. This agreement has expired and we have no finder’s fee commitment.
	On March 4, 2014, the Company entered into a one-year consulting agreement which includes cash payments of $3,500 per month and the issuance of 220,000 warrants per month. The warrants carry a three-year term from the issuance date and an exercise price of $0.04.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Nov. 30, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	11	SUBSEQUENT EVENTS
	Management has evaluated subsequent events through the date of this filing.   There are no subsequent events to disclose.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Nov. 30, 2014
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]		a.	Basis of Presentation - The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred net losses of approximately $37.2 million since inception, including a net loss of approximately $1.5 million for the six months ended November 30, 2014. Additionally, the Company still had both working capital and stockholders’ deficiencies at November 30, 2014 and May 31, 2014 and negative cash flow from operations since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management expects to incur additional losses in the foreseeable future and recognizes the need to raise capital to remain viable. The accompanying consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.
Consolidation, Policy [Policy Text Block]		b.	Principles of consolidation - The consolidated financial statements include the accounts of Arkados Group, Inc. (the “Parent”), and its wholly-owned subsidiaries, which include: Arkados Energy Solutions, LLC, Arkados, Inc., CDKnet, LLC and Creative Technology, LLC. Currently, Arkados, Inc. is the only active entity with operations. Intercompany accounts and transactions have been eliminated in consolidation.
Revenue Recognition, Policy [Policy Text Block]		c.	Revenue Recognition - Revenues from software licensing are recognized in accordance with ASC 985-605, "Software Revenue Recognition." Accordingly, revenue from software licensing is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collectability is probable.
	The Company intends to enter into arrangements with end users for items which may include software license fees, and services or various combinations thereof. For each arrangement, revenues will be recognized when evidence of an agreement has been documented, the fees are fixed or determinable, collection of fees is probable, delivery of the product has occurred and no other significant obligations remain.
	License revenues are recognized at the time of delivery of the software and all other revenue recognition criteria discussed above have been met.
Cash and Cash Equivalents, Policy [Policy Text Block]		d.	Cash and cash equivalents - The Company considers investments in highly liquid instruments with a maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents at both November 30, 2014 and May 31, 2014.
Fair Value of Financial Instruments, Policy [Policy Text Block]		e.	Fair Value of Financial Instruments - The carrying value of cash, accounts receivable, other receivables, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. As defined in Accounting Standards Codification (“ASC”) Topic No. 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.
	The three levels of the fair value hierarchy defined by ASC Topic No. 820 are as follows:
	Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
	Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
Earnings Per Share, Policy [Policy Text Block]		f.	Earnings (Loss) Per Share (“EPS”) - Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes.
	The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares.
			Three and Six Months ended
			November 30,
			2014		2013
	Convertible notes			63,475,550		50,000,000
	Stock options			35,437,500		2,960,000
	Warrants			92,479,696		5,095,000
	Potentially dilutive securities			191,392,746		58,055,000
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]		g.	Stock Based Compensation - In computing the impact, the fair value of each option and/or warrant is estimated on the date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility; and expected remaining lives of the awards. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and the Company uses different assumptions, the Company’s stock-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the amount of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what we have recorded in the current period.
	Stock based compensation expense was $37,000 and $219,834 for the three months ended November 30, 2014 and 2013, respectively, and $1,037,000 and $219,834 for the six months ended November 30, 2014 and 2013, respectively. The expense was included in selling and general and administrative expenses. See Note 6h.
Use of Estimates, Policy [Policy Text Block]		h.	Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.
Research and Development Expense, Policy [Policy Text Block]		i.	Research and Development –All research and development costs are expensed as incurred.
New Accounting Pronouncements, Policy [Policy Text Block]		j.	New Accounting Pronouncements –
	In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” The amendments in ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in ASC 605, “Revenue Recognition,” and most industry-specific guidance, and creates an ASC 606, “Revenue from Contracts with Customers.”
	The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps
	Step 1: Identify the contract(s) with a customer.
	Step 2: Identify the performance obligations in the contract.
	Step 3: Determine the transaction price.
	Step 4: Allocate the transaction price to the performance obligations in the contract.
	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
	ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted. The Company’s has not yet determined the effect to the current consolidated financial statements by the adoption of ASU 2014-09.
	In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Subtopic 205-40) – Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this Update provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this Update are effective for public and nonpublic entities for annual periods ending after December 15, 2016 and early adoption is permitted.
	All newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.
Reclassification, Policy [Policy Text Block]		k.	Reclassification –
	Certain amounts in the consolidated statement of cash flow for the six months ended November 30, 2013 were reclassified to conform to the current period presentation. For the six months ended November 30, 2013, the Company did not originally segregate issuances of common stock and warrants for services

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Nov. 30, 2014
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares.
		Three and Six Months ended
		November 30,
		2014		2013
	Convertible notes		63,475,550		50,000,000
	Stock options		35,437,500		2,960,000
	Warrants		92,479,696		5,095,000
	Potentially dilutive securities		191,392,746		58,055,000

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	6 Months Ended
	Nov. 30, 2014
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	As of November 30, 2014 and May 31, 2014, accounts payable and accrued expenses consist of the following amounts:
		November 30, 2014		May 31, 2014
		(Unaudited)
	Accounts payable	$	375,494	$	396,324
	Accrued interest		176,956		137,736
	Accrued other		140,805		127,808
		$	693,255	$	661,868

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	6 Months Ended
	Nov. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Activity [Table Text Block]	Compensation based stock option activity for qualified and unqualified stock options are summarized as follows:
				Weighted
				Average
		Shares		Exercise Price
	Outstanding at May 31, 2013		2,960,000	$	0.29
	Granted		35,437,500		0.04
	Exercised		—		—
	Expired or cancelled		-960,000		0.36
	Outstanding at May 31, 2014		37,437,500		0.05
	Granted		—		—
	Exercised		—		—
	Expired or cancelled		-2,000,000		0.25
	Outstanding at November 30, 2014		35,437,500	$	0.04
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	The following table summarizes information about options outstanding and exercisable at November 30, 2014:
		Options Outstanding and exercisable
		Number		Weighted-		Weighted-		Number
		Outstanding		Average		Average		Exercisable
				Remaining Life		Exercise
				In Years		Price
	Range of exercise prices:
	$0.04		35,437,500		9.39	$	0.04		35,437,500
Schedule of Share-based Compensation, Warrants, Activity [Table Text Block]	The issuance of warrants attributed to debt issuances are summarized as follows:
				Weighted
				Average
		Shares		Exercise Price
	Outstanding at May 31, 2013		2,350,080	$	0.19
	Granted		72,031,284		0.04
	Exercised		—		—
	Expired or cancelled		-2,350,080		0.7
	Outstanding at May 31, 2014		72,031,284		0.04
	Granted		20,448,412		0.04
	Exercised		—		—
	Expired or cancelled		—		—
	Outstanding at November 30, 2014		92,479,696	$	0.04
Schedule of Other Share-based Compensation, Activity [Table Text Block]	The following table summarizes information about warrants outstanding and exercisable at November 30, 2014:
		Outstanding and exercisable
		Number		Weighted-		Weighted-		Number
		Outstanding		average		Average		Exercisable
				remaining life		Exercise
				in years		Price
	Range of exercise prices:
	$0.00 to $0.04		89,479,696		4.65	$	0.04		89,479,696
	$0.05 to $0.20		3,000,000		1.98		0.15		3,000,000
			92,479,696		4.56	$	0.04		92,479,696

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (Exercise Price Less Than Average Market Price Of Common Stock [Member])	3 Months Ended		6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014	Nov. 30, 2013
Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	191,392,746	58,055,000	191,392,746	58,055,000
Convertible Notes Payable [Member]
Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	63,475,550	50,000,000	63,475,550	50,000,000
Equity Option [Member]
Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	35,437,500	2,960,000	35,437,500	2,960,000
Warrant [Member]
Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	92,479,696	5,095,000	92,479,696	5,095,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)	3 Months Ended		6 Months Ended		128 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014
Accounting Policies [Line Items]
Net income (loss)	($202,458)	($548,667)	($1,517,488)	($874,057)	$37,200,000
Stock based compensation	$37,000	$219,834	$1,037,000	$219,834

SALE_OF_LICENSE_AND_IP_AGREEME1

SALE OF LICENSE AND IP AGREEMENTS (Details Textual) (USD $)	1 Months Ended	12 Months Ended
	Jun. 30, 2011	31-May-11
Finite-Lived Intangible Assets [Line Items]
Proceeds from Sale of Intangible Assets		$7,000,000
Proceeds from Sale of Other Assets	4,000,000
Secured Debt		20,000,000
Workers Compensation Liability		1,400,000
Employee-related Liabilities		5,200,000
Payments for Legal Settlements		7,000,000
Payments to Employees		1,429,949
Settlement Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Accounts Payable		30,000,000
Extinguishment of Debt, Amount		10,862,241
Payments for Restructuring	3,862,241
Unsecured Debt		2,100,000
Settlement Agreements [Member] | Equity [Member]
Finite-Lived Intangible Assets [Line Items]
Extinguishment of Debt, Amount		5,259,926
Settlement Agreements [Member] | Notes Payable, Other Payables [Member]
Finite-Lived Intangible Assets [Line Items]
Extinguishment of Debt, Amount		$818,768

ACCOUNTS_PAYABLE_AND_ACCRUED_E2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) (USD $)	Nov. 30, 2014	31-May-14
Accounts Payable And Accrued Expenses [Line Items]
Accounts payable	$375,494	$396,324
Accrued interest	176,956	137,736
Accrued other	140,805	127,808
Accrued Liabilities	$693,255	$661,868

ACCOUNTS_PAYABLE_AND_ACCRUED_E3

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Textual) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014	Nov. 30, 2013	31-May-14	Sep. 19, 2013	Nov. 20, 2013
Accounts Payable And Accrued Expenses [Line Items]
Debt Conversion, Converted Instrument, Shares Issued			23,776,513
Accounts Payable, Current	$375,494		$375,494		396,324
Other Nonoperating Income	124,793	0	124,793	0
Settlement Agreement On September 10, 2013 [Member]
Accounts Payable And Accrued Expenses [Line Items]
Debt Conversion, Converted Instrument, Shares Issued			23,776,513
Accounts Payable, Current	0		0		0
Settlement Agreement On September 19, 2013 [Member]
Accounts Payable And Accrued Expenses [Line Items]
Accounts Payable, Current						130,863
Settlement Agreement On November 20, 2013 [Member]
Accounts Payable And Accrued Expenses [Line Items]
Debt Conversion, Converted Instrument, Shares Issued					5,682,407
Accounts Payable, Current							$207,943

NOTES_PAYABLE_RELATED_PARTY_PA1

NOTES PAYABLE, RELATED PARTY PAYABLES AND DEBT SUBJECT TO EQUITY BEING ISSUED (Details Textual) (USD $)	1 Months Ended		3 Months Ended			6 Months Ended		12 Months Ended			1 Months Ended			0 Months Ended			1 Months Ended						12 Months Ended
	Jun. 30, 2011	Dec. 31, 2010	Nov. 30, 2014	Nov. 30, 2013	Aug. 31, 2012	Nov. 30, 2014	Nov. 30, 2013	31-May-14	31-May-13	31-May-12	Mar. 31, 2014	Dec. 31, 2013	Apr. 30, 2014	Sep. 10, 2014	Aug. 11, 2014	Aug. 12, 2014	Nov. 30, 2013	Oct. 31, 2013	31-May-13	Apr. 30, 2013	Dec. 31, 2012	Nov. 30, 2012	31-May-15	31-May-10	Sep. 11, 2013	Jan. 06, 2013	Nov. 12, 2013	Oct. 28, 2013	2-May-13	Apr. 22, 2013	Sep. 19, 2013
Related Party Transaction [Line Items]
Convertible Debt																								17,269,689
Interest Payable																								3,671,137
Convertible Notes Payable, Current										688,768
Proceeds from Convertible Debt						200,000	400,000	400,000	600,000
Repayments of Notes Payable	3,526,523	5,570,059
Due to Related Parties, Current			0			0		130,000
Derivative, Number of Instruments Held																								11,075,004
Gains (Losses) on Extinguishment of Debt, Total			44,071	0		44,071	0			482,784
Convertible Debt, Current			1,224,591			1,224,591		2,420,374
Debt Instrument, Convertible, Beneficial Conversion Feature								107,500	600,000
Notes Payable			1,357,233			1,357,233		939,894
Notes Payable Unamortized Discount Current			188,600			188,600		231,818
Debt Conversion, Converted Instrument, Shares Issued						23,776,513
Exercise Price of Warrant								$0.04
Stock Issued						1,835,486	0
Proceeds from Related Party Debt					130,000
Settlement Agreement On September 6, 2013 [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Shares Issued								1,204,630
Debt Instrument, Increase, Accrued Interest								18,190
Settlement Agreement On September 9, 2013 [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Shares Issued								2,478,417
Debt Instrument, Increase, Accrued Interest								74,286
Debt Instrument, Maturity Date Range, End								9-Sep-16
Debt Instrument, Term								3 years
Settlement Agreement On September 11, 2013 [Member]
Related Party Transaction [Line Items]
Due to Related Parties, Current																									15,000
Repayments of Debt											7,500	7,500
Settlement Agreement On November 30 2014 [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, New Issues						19,456,874
Debt Conversion, Original Debt, Amount						466,000
Typaldos Son [Member]
Related Party Transaction [Line Items]
Due to Related Parties, Current																										19,000
Andreas Typaldos [Member]
Related Party Transaction [Line Items]
Due to Related Parties, Current			0			0		0																		15,920
Stock Issued During Period, Shares, New Issues									14,073,966
Stock Issued									14,073,966
Former Employees [Member]
Related Party Transaction [Line Items]
Due to Employees, Current			179,000			179,000		927,000
Former Employees [Member] | Settlement Agreement On April 2014 [Member]
Related Party Transaction [Line Items]
Exercise Price of Warrant													$0.04
Warrant Expiration Period													5 years
Debt Conversion, Original Debt, Amount													2,695,052
Convertible Notes Payable [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount														65,000	100,000	100,000					20,000	180,000					200,000	200,000	200,000	120,000
Debt Instrument, Interest Rate, Stated Percentage														6.00%	6.00%	6.00%					6.00%	6.00%					6.00%	6.00%	6.00%	6.00%
Debt Instrument, Maturity Date						31-Oct-15								31-Oct-15	31-Oct-15	31-Oct-15	31-Oct-15	31-Oct-15	30-Apr-15	30-Apr-15	15-Nov-14	15-Nov-14
Debt Instrument, Convertible, Conversion Price														$0.04	$0.02	$0.02					$0.01	$0.01					$0.04	$0.04	$0.02	$0.02
Debt Instrument, Convertible, Beneficial Conversion Feature															35,500	35,500	100,000	7,500	200,000	120,000	20,000	180,000
Debt Instrument, Interest Rate, Increase (Decrease)																					12.00%
Notes Payable Unamortized Discount Current			188,600			188,600		309,263
Debt Instrument, Maturity Date Range, End																					31-Jan-15	15-Jan-15
promissory Notes Payable [Member] | Settlement Agreement On September 19, 2013 [Member]
Related Party Transaction [Line Items]
Notes Payable																															121,736
Subsequent Event [Member] | Former Employees [Member] | Settlement Agreement On May 31 2015 [Member]
Related Party Transaction [Line Items]
Exercise Price of Warrant																							$0.04
Warrant Expiration Period																							5 years
Debt Conversion, Original Debt, Amount																							747,537
Two Convertible Notes Payable [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount																														40,000
Debt Instrument, Interest Rate, Stated Percentage																														6.00%
Debt Instrument, Maturity Date																				30-Apr-15
Debt Instrument, Convertible, Conversion Price																														$0.02
Debt Instrument, Convertible, Beneficial Conversion Feature																				40,000
Debt Instrument, Increase, Accrued Interest														174,071
Warrant [Member]
Related Party Transaction [Line Items]
Fair Value Assumptions, Expected Volatility Rate																								0.00%
Warrant [Member] | Settlement Agreement On September 9, 2013 [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Shares Issued								1,435,000
Exercise Price of Warrant								$0.04
Warrant [Member] | Former Employees [Member] | Settlement Agreement On April 2014 [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, New Issues													67,376,284
Warrant [Member] | Subsequent Event [Member] | Former Employees [Member] | Settlement Agreement On May 31 2015 [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, New Issues																							18,688,412
Warrant [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Fair Value Assumptions, Risk Free Interest Rate																								1.39%
Fair Value Assumptions, Expected Term																								2 years
Fair Value Assumptions, Expected Volatility Rate																								251.00%
Warrant [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Fair Value Assumptions, Risk Free Interest Rate																								1.32%
Fair Value Assumptions, Expected Term																								6 months
Fair Value Assumptions, Expected Volatility Rate																								206.00%
Common Stock [Member] | Settlement Agreement On September 11, 2013 [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Shares Issued								3,500,000
Debt Conversion, Original Debt, Amount								$125,000

STOCKHOLDERS_DEFICIENCY_Detail

STOCKHOLDERS' DEFICIENCY (Details Textual) (USD $)	6 Months Ended		12 Months Ended		1 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	31-May-14	31-May-13	Mar. 31, 2014	Jul. 16, 2014	Mar. 17, 2014
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	23,776,513
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$0		$0.04
Debt Instrument, Convertible, Beneficial Conversion Feature			$107,500	$600,000
Exercise Price of Warrant			$0.04
Proceeds from Convertible Debt	200,000	400,000	400,000	600,000
Shares To Be Issued For Bridge Notes And Accrued Interest			3,683,047
Warrants Issued For Bridge Notes And Accrued Interest, Conversion Rights			1,435,000
Stock To Be Issued For Bridge Notes And Accrued Interest			73,428
Warrants To Be Issued For Bridge Notes And Accrued Interest	0	19,047	19,047
Stock To Be Issued For Debt Subject To Equity Being Issued			3,500,000
Debt Conversion, Converted Instrument, Amount	0	73,428
Stock To Be Issued For Consulting Agreements			217,000
Adjustments to Additional Paid in Capital, Warrant Issued	747,536	0
Common Stock, Shares Authorized	600,000,000		600,000,000				100,000,000
Common Stock, Par or Stated Value Per Share	$0.00		$0.00			$0.05
Settlement Agreement On November 30 2014 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues	19,456,874
Debt Conversion, Original Debt, Amount	466,000
Accounts Payable [Member]
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Amount	550,000		338,806
Maximum [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$0.02
Minimum [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$0.01
Mr. Andreas Typaldos [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				14,073,966
Investor [Member]
Class of Stock [Line Items]
Sale of Stock, Consideration Received on Transaction					400,000
Common Stock [Member]
Class of Stock [Line Items]
Stock To Be Issued For Debt Subject To Equity Being Issued			125,000
Stock To Be Issued For Consulting Agreements	20,000,000
Consultant [Member] | Common Stock [Member]
Class of Stock [Line Items]
Shares To Be Issued For Consulting Agreements			3,100,000
Warrants Issued For Consulting Agreements, Conversion Rights			3,000,000
Adjustments to Additional Paid in Capital, Warrant Issued			2,834
Consultant [Member] | Warrant [Member]
Class of Stock [Line Items]
Exercise Price of Warrant			$0.04
Consultant [Member] | Warrant [Member] | Maximum [Member]
Class of Stock [Line Items]
Exercise Price of Warrant			$0.20
Consultant [Member] | Warrant [Member] | Minimum [Member]
Class of Stock [Line Items]
Exercise Price of Warrant			$0.10
Vendor [Member]
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Shares Issued			6,682,407
Sale of Stock, Number of Shares Issued in Transaction					10,000,000
Promissory Note [Member] | Common Stock [Member]
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Amount			121,736
Promissory Note [Member] | Accrued Liabilities [Member]
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Amount	$310,977

STOCKBASED_COMPENSATION_Detail

STOCK-BASED COMPENSATION (Details) (USD $)	6 Months Ended	12 Months Ended
	Nov. 30, 2014	31-May-14
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares)	37,437,500	2,960,000
Outstanding (in dollars per share)	$0.05	$0.29
Granted (in shares)	0	35,437,500
Granted (in dollars per share)	$0	$0.04
Exercised (in shares)	0	0
Exercised (in dollars per share)	$0	$0
Expired or cancelled (in shares)	-2,000,000	-960,000
Expired or cancelled (in dollars per share)	$0.25	$0.36
Outstanding (in shares)	35,437,500	37,437,500
Outstanding (in dollars per share)	$0.04	$0.05

STOCKBASED_COMPENSATION_Detail1

STOCK-BASED COMPENSATION (Details 1) (USD $)	6 Months Ended
	Nov. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of exercise prices:	$0.04
Number Outstanding	35,437,500
Weighted-Average Remaining Life In Years	9 years 4 months 20 days
Weighted- Average Exercise Price (in dollars per share)	$0.04
Number Exercisable	35,437,500

STOCKBASED_COMPENSATION_Detail2

STOCK-BASED COMPENSATION (Details 2) (Warrant [Member], USD $)	6 Months Ended	12 Months Ended
	Nov. 30, 2014	31-May-14
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares)	72,031,284	2,350,080
Outstanding (in dollars per shares)	$0.04	$0.19
Granted (in shares)	20,448,412	72,031,284
Granted (in dollars per shares)	$0.04	$0.04
Exercised (in shares)	0	0
Exercised (in dollars per shares)	$0	$0
Expired or cancelled (in shares)	0	-2,350,080
Expired or cancelled (in dollars per shares)	$0	$0.70
Outstanding (in shares)	92,479,696	72,031,284
Outstanding (in dollars per shares)	$0.04	$0.04

STOCKBASED_COMPENSATION_Detail3

STOCK-BASED COMPENSATION (Details 3) (Warrant [Member], USD $)	6 Months Ended
	Nov. 30, 2014	31-May-14	31-May-13
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Outstanding	92,479,696	72,031,284	2,350,080
Weighted-average remaining life in years	4 years 6 months 22 days
Weighted-Average Exercise Price (in dollars per share)	$0.04
Number Exercisable	92,479,696
Range One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of exercise prices, Minimum	$0
Range of exercise prices, Maximum	$0.04
Number Outstanding	89,479,696
Weighted-average remaining life in years	4 years 7 months 24 days
Weighted-Average Exercise Price (in dollars per share)	$0.04
Number Exercisable	89,479,696
Range Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of exercise prices, Minimum	$0.05
Range of exercise prices, Maximum	$0.20
Number Outstanding	3,000,000
Weighted-average remaining life in years	1 year 11 months 23 days
Weighted-Average Exercise Price (in dollars per share)	$0.15
Number Exercisable	3,000,000

STOCKBASED_COMPENSATION_Detail4

STOCK-BASED COMPENSATION (Details Textual) (USD $)	6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt Conversion, Converted Instrument, Warrants or Options Issued	18,688,412
Issuance of Stock and Warrants for Services or Claims	$37,000	$2,834
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Strike Price	$0.04
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	100.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.50%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	3 years
Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of Stock and Warrants for Services or Claims	$1,760,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Share Price	$0.06
Maximum [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	10 years
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Share Price	$0.02
Minimum [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	3 years

LICENSE_AGREEMENTS_Details_Tex

LICENSE AGREEMENTS (Details Textual) (USD $)	3 Months Ended	6 Months Ended
	Nov. 30, 2014	Nov. 30, 2014
Master Agreement License of Process and Event Management System [Member]
License Agreements [Line Items]
License and Services Revenue	$58,996	$98,996
Percentage Of Fees For Software Services		10.00%
Agreement License of Meter Collar and Bridge Programmable Logic Controllers [Member]
License Agreements [Line Items]
License and Services Revenue	$20,000	$20,000

PROVISION_FOR_INCOME_TAX_BENEF1

PROVISION FOR INCOME TAX BENEFITS (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014	Nov. 30, 2013
Provision For Income Tax Benefits [Line Items]
Provision for income tax benefits	$35,840	$0	$35,840	$0

COMMITMENTS_Details_Textual

COMMITMENTS (Details Textual) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014	Nov. 30, 2013	31-May-14	Nov. 20, 2013
Loss Contingencies [Line Items]
Operating Leases, Rent Expense, Net, Total	$5,004	$5,004	$10,008	$10,008
Common Stock To Be Issued Shares	0		0		37,850,479
Revenue Receipts Threshold One			500,000
Revenue Receipts Threshold Two			2,000,000
Revenue Receipts Threshold Three			4,000,000
Percentage Of Finder's Fee Paid to Consultants					7.00%
Exercise Price of Warrant					$0.04
Issuance of Stock and Warrants for Services or Claims			37,000	2,834
Chief Executive Officer [Member]
Loss Contingencies [Line Items]
Rental Income, Nonoperating			1,668
Rental Income Frequency Of Periodic Payment			month-to-month
Consultant [Member]
Loss Contingencies [Line Items]
Stock Issued During Period, Shares, Issued for Services			20,000,000		3,000,000
Common Stock To Be Issued Shares	30,000,000		30,000,000
Payments for Fees					3,500
Issuance of Stock and Warrants for Services or Claims			1,760,000
Consultant [Member] | Warrant [Member]
Loss Contingencies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						3,000,000
Exercise Price of Warrant					$0.04
Issuance of Stock and Warrants for Services or Claims					$220,000
Warrant Expiration Period					3 years
Consultant [Member] | Maximum [Member] | Warrant [Member]
Loss Contingencies [Line Items]
Exercise Price of Warrant					$0.20
Consultant [Member] | Minimum [Member] | Warrant [Member]
Loss Contingencies [Line Items]
Exercise Price of Warrant					$0.10